Literature DB >> 32691969

Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer.

Zachary T Rosenkrans1, Carolina A Ferreira2, Dalong Ni2, Weibo Cai1,2.   

Abstract

Advances in technology and nanomedicine have led to the development of nanoparticles that can be activated for multimodal imaging of cancer, where a stimulus induces a material modification that enhances image contrast. Multimodal imaging using nanomaterials with this capability can combine the advantages and overcome the limitations of any single imaging modality. When designed with stimuli-responsive abilities, the target-to-background ratio of multimodal imaging nanoprobes increases because specific stimuli in the tumor enhance the signal. Several aspects of the tumor microenvironment can be exploited as an internal stimulus response for multimodal imaging applications, such as the pH gradient, redox processes, overproduction of various enzymes, or combinations of these. In this review, design strategies are discussed and an overview of the recent developments of internally responsive multimodal nanomaterials is provided. Properly implementing this approach improves noninvasive cancer diagnosis and staging as well as provides a method to monitor drug delivery and treatment response.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bioresponsive materials; internally responsive materials; multimodal imaging; nanomedicine

Mesh:

Year:  2020        PMID: 32691969      PMCID: PMC7855763          DOI: 10.1002/adhm.202000690

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  95 in total

Review 1.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Multifunctional gold nanoparticles as smart nanovehicles with enhanced tumour-targeting abilities for intracellular pH mapping and in vivo MR/fluorescence imaging.

Authors:  Kang-Kang Yu; Kun Li; Chun-Yan Lu; Yong-Mei Xie; Yan-Hong Liu; Qian Zhou; Jin-Ku Bao; Xiao-Qi Yu
Journal:  Nanoscale       Date:  2020-01-23       Impact factor: 7.790

Review 3.  Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers.

Authors:  T Turpeenniemi-Hujanen
Journal:  Biochimie       Date:  2005 Mar-Apr       Impact factor: 4.079

4.  Intelligent nanoflowers: a full tumor microenvironment-responsive multimodal cancer theranostic nanoplatform.

Authors:  Xunan Jing; Yanzi Xu; Daomeng Liu; Youshen Wu; Na Zhou; Daquan Wang; Kai Yan; Lingjie Meng
Journal:  Nanoscale       Date:  2019-08-08       Impact factor: 7.790

Review 5.  Therapeutic targets in cancer cell metabolism and autophagy.

Authors:  Heesun Cheong; Chao Lu; Tullia Lindsten; Craig B Thompson
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

Review 6.  Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.

Authors:  W Nathaniel Brennen; John T Isaacs; Samuel R Denmeade
Journal:  Mol Cancer Ther       Date:  2012-02       Impact factor: 6.261

Review 7.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Authors:  L Ouyang; Z Shi; S Zhao; F-T Wang; T-T Zhou; B Liu; J-K Bao
Journal:  Cell Prolif       Date:  2012-10-03       Impact factor: 6.831

Review 8.  Glutathione levels in human tumors.

Authors:  Michael P Gamcsik; Mohit S Kasibhatla; Stephanie D Teeter; O Michael Colvin
Journal:  Biomarkers       Date:  2012-08-20       Impact factor: 2.658

Review 9.  Multimodality Imaging Agents with PET as the Fundamental Pillar.

Authors:  Dalong Ni; Emily B Ehlerding; Weibo Cai
Journal:  Angew Chem Int Ed Engl       Date:  2018-12-11       Impact factor: 15.336

View more
  8 in total

Review 1.  The Advances and Biomedical Applications of Imageable Nanomaterials.

Authors:  Xiaohong Xiang; Doudou Shi; Jianbo Gao
Journal:  Front Bioeng Biotechnol       Date:  2022-07-05

2.  Elaborate design of shell component for manipulating the sustained release behavior from core-shell nanofibres.

Authors:  Yubo Liu; Xiaohong Chen; Yuhang Gao; Deng-Guang Yu; Ping Liu
Journal:  J Nanobiotechnology       Date:  2022-05-28       Impact factor: 9.429

Review 3.  Carbon Graphitization: Towards Greener Alternatives to Develop Nanomaterials for Targeted Drug Delivery.

Authors:  Davide Marin; Silvia Marchesan
Journal:  Biomedicines       Date:  2022-06-04

4.  A nitroxides-based macromolecular MRI contrast agent with an extraordinary longitudinal relaxivity for tumor imaging via clinical T1WI SE sequence.

Authors:  Shiwei Guo; Xiaoming Wang; Zhiqian Li; Dayi Pan; Yan Dai; Yun Ye; Xiaohe Tian; Zhongwei Gu; Qiyong Gong; Hu Zhang; Kui Luo
Journal:  J Nanobiotechnology       Date:  2021-08-14       Impact factor: 10.435

5.  ROS-responsive 18β-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation.

Authors:  Lulu Jin; Zhixin Zhu; Liangjie Hong; Zhefeng Qian; Fang Wang; Zhengwei Mao
Journal:  Bioact Mater       Date:  2022-04-01

Review 6.  Bioresponsive Nanomaterials: Recent Advances in Cancer Multimodal Imaging and Imaging-Guided Therapy.

Authors:  Zeng Zeng; Huali Gao; CongXian Chen; Lianbo Xiao; Kun Zhang
Journal:  Front Chem       Date:  2022-03-18       Impact factor: 5.221

7.  Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics.

Authors:  Xiawei Dong; Jing Ye; Yihan Wang; Hongjie Xiong; Hui Jiang; Hongbing Lu; Xiaohui Liu; Xuemei Wang
Journal:  Biosensors (Basel)       Date:  2022-07-24

8.  HOCl-Activated Aggregation of Gold Nanoparticles for Multimodality Therapy of Tumors.

Authors:  Dongya Liu; Lingyan Liu; Feiyang Liu; Mengfan Zhang; Peng Wei; Tao Yi
Journal:  Adv Sci (Weinh)       Date:  2021-07-08       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.